Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
Stopped Terminated at the request of the study sponsor
Conditions
- Chronic Myeloproliferative Disorders
- Graft Versus Host Disease
- Infection
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic-Myeloproliferative Diseases
- Neuroblastoma
- Therapy-related Toxicity
Interventions
- BIOLOGICAL: immunosuppressive therapy
- OTHER: immunological diagnostic method
- PROCEDURE: allogeneic hematopoietic stem cell transplantation
Sponsor
City of Hope Medical Center
Collaborators